215523-07-2 Usage
Uses
Used in Pharmaceutical Industry:
CBZ-L-CYCLOPROPYL-ALA-OH is used as a key component in the development of novel peptides for various pharmaceutical applications. Its unique properties allow for the creation of peptides with enhanced stability, selectivity, and bioactivity, which can be crucial for drug discovery and therapeutic interventions.
Used in Research and Development:
In the field of research, CBZ-L-CYCLOPROPYL-ALA-OH is utilized as a building block for synthesizing peptides with altered properties. This enables scientists to study protein folding, binding interactions, and other biochemical processes, contributing to a deeper understanding of protein function and the development of new therapeutic strategies.
Used in Peptide Synthesis:
CBZ-L-CYCLOPROPYL-ALA-OH is employed as a crucial component in peptide synthesis, where its cyclopropyl side chain and carboxybenzyl protecting group contribute to the controlled formation of peptide bonds and the synthesis of peptides with specific characteristics. This makes it an essential tool for creating custom peptides for various applications, including drug development, diagnostics, and research.
Check Digit Verification of cas no
The CAS Registry Mumber 215523-07-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,5,5,2 and 3 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 215523-07:
(8*2)+(7*1)+(6*5)+(5*5)+(4*2)+(3*3)+(2*0)+(1*7)=102
102 % 10 = 2
So 215523-07-2 is a valid CAS Registry Number.
215523-07-2Relevant articles and documents
SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
-
Page/Page column 116; 117, (2011/04/14)
Compounds of Formula I: and salts thereof in which R1, R2, R2a, R3, n, X and ring B have the meanings given in the specification, are inhibitors of mTOR and are useful in the treatment of diseases which are sensitive to inhibition of mTOR, such as cancers.
Protease inhibitors
-
, (2008/06/13)
The present invention provides bis-aminomethylcarbonyl compounds that are inhibitors of cysteine and serine proteases. The compounds are particularly useful for treating diseases in which excess cysteine protease activity has been implicated, including osteoporosis, periodontitis and arthritis.
